Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism

Medical Hypotheses

Volumn 68, Issue 6, 2007, Pages 1208-1227

  Rossignol, Daniel A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PORPHYRIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; AUTISM; BRAIN BLOOD FLOW; CORRELATION ANALYSIS; DETOXIFICATION; DIGESTIVE SYSTEM INFLAMMATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEMATOPOIETIC STEM CELL; HUMAN; HYPERBARIC OXYGEN; IMMUNE DYSREGULATION; IMMUNE FUNCTION TEST; MICROGLIA; NERVE CELL DIFFERENTIATION; NEUROTRANSMISSION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SOCIAL INTERACTION; STEREOTYPY; UPREGULATION;

AUTISTIC DISORDER; CHILD; HUMANS; HYPERBARIC OXYGENATION; MODELS, BIOLOGICAL;

EID: 33947701000     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.09.064     Document Type: Article

References (270)

1. Singh N. (contact). Press release: CDC launches "Learn the signs. Act early." Campaign. http://www.cdc.gov/od/oc/media/pressrel/r050222.htm. February 22, 2005 [accessed 9.5.06].
2. Baird G., Simonoff E., Pickles A., et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the special needs and autism project (SNAP). Lancet 368 9531 (2006) 210-215
3. Shaul M. (contact). GAO-05-220. United States Government Accountability Office. Report to the chairman and ranking minority member, subcommittee on human rights and wellness, committee on government reform, house of representatives. Special education: children with autism. http://www.gao.gov/new.items/d05220.pdf. January 2005 [accessed 9.5.06].
4. Kanner L. Autistic disturbances of affective contact. Nervous Child 2 (1943) 217-250
5. London E.A. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect 108 S3 (2000) 401-404
6. Baird G., Cass H., and Slonims V. Diagnosis of autism. BMJ 327 7413 (2003) 488-493
7. Klauck S.M. Genetics of autism spectrum disorder. Eur J Hum Genet 14 6 (2006) 714-720
8. Charman T., Taylor E., Drew A., Cockerill H., Brown J.A., and Baird G. Outcome at 7 years of children diagnosed with autism at age 2: predictive validity of assessments conducted at 2 and 3 years of age and pattern of symptom change over time. J Child Psychol Psychiatry 46 5 (2005) 500-513
9. Lord C., Risi S., DiLavore P.S., Shulman C., Thurm A., and Pickles A. Autism for 2 to 9 years of age. Arch Gen Psychiatry 63 6 (2006) 694-701
10. Ryu Y.H., Lee J.D., Yoon P.H., Kim D.I., Lee H.B., and Shin Y.J. Perfusion impairments in infantile autism on technetium-99m ethyl cysteinate dimer brain single-photon emission tomography: comparison with findings on magnetic resonance imaging. Eur J Nucl Med 26 3 (1999) 253-259
11. Wilcox J., Tsuang M.T., Ledger E., Algeo J., and Schnurr T. Brain perfusion in autism varies with age. Neuropsychobiology 46 1 (2002) 13-16
12. Chiron C., Leboyer M., Leon F., Jambaque I., Nuttin C., and Syrota A. SPECT of the brain in childhood autism: evidence for a lack of normal hemispheric asymmetry. Dev Med Child Neurol 37 10 (1995) 849-860
13. Starkstein S.E., Vazquez S., Vrancic D., et al. SPECT findings in mentally retarded autistic individuals. J Neuropsychiatry Clin Neurosci 12 3 (2000) 370-375
14. Mountz J.M., Tolbert L.C., Lill D.W., Katholi C.R., and Liu H.G. Functional deficits in autistic disorder: characterization by technetium-99m-HMPAO and SPECT. J Nucl Med 36 7 (1995) 1156-1162
15. Ohnishi T., Matsuda H., Hashimoto T., et al. Abnormal regional cerebral blood flow in childhood autism. Brain 123 Pt9 (2000) 1838-1844
16. George M.S., Costa D.C., Kouris K., Ring H.A., and Ell P.J. Cerebral blood flow abnormalities in adults with infantile autism. J Nerv Ment Dis 180 7 (1992) 413-417
17. Boddaert N., and Zilbovicius M. Functional neuroimaging and childhood autism. Pediatr Radiol 32 1 (2002) 1-7
18. Zilbovicius M., Boddaert N., Belin P., et al. Temporal lobe dysfunction in childhood autism: a PET study. Am J Psychiatry 157 12 (2000) 1988-1993
19. Kaya M., Karasalihoglu S., Ustun F., et al. The relationship between 99mTc-HMPAO brain SPECT and the scores of real life rating scale in autistic children. Brain Dev 24 2 (2002) 77-81
20. Hashimoto T., Sasaki M., Fukumizu M., Hanaoka S., Sugai K., and Matsuda H. Single-photon emission computed tomography of the brain in autism: effect of the developmental level. Pediatr Neurol 23 5 (2000) 416-420
21. Gillberg I.C., Bjure J., Uvebrant P., Vestergren E., and Gillberg C. SPECT (single photon emission computed tomography) in 31 children and adolescents with autism and autism-like conditions. Eur Child Adolesc Psychiatry 2 1 (1993) 50-59
22. Boddaert N., Chabane N., Belin P., et al. Perception of complex sounds in autism: abnormal auditory cortical processing in children. Am J Psychiatry 161 11 (2004) 2117-2120
23. 99mTc-ECD SPECT in high-functioning autism-3-dimensional stereotactic ROI template analysis of brain SPECT. J Med Invest 52 1-2 (2005) 49-56
24. Critchley H.D., Daly E.M., Bullmore E.T., et al. The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 123 Pt11 (2000) 2203-2212
25. Pierce K., Haist F., Sedaghat F., and Courchesne E. The brain response to personally familiar faces in autism: findings of fusiform activity and beyond. Brain 127 Pt12 (2004) 2703-2716
26. Allen G., and Courchesne E. Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am J Psychiatry 160 2 (2003) 262-273
27. Muller R.A., Behen M.E., Rothermel R.D., et al. Brain mapping of language and auditory perception in high-functioning autistic adults: a PET study. J Autism Dev Disord 29 1 (1999) 19-31
28. Bruneau N., Dourneau M.C., Garreau B., Pourcelot L., and Lelord G. Blood flow response to auditory stimulations in normal, mentally retarded, and autistic children: a preliminary transcranial Doppler ultrasonographic study of the middle cerebral arteries. Biol Psychiatry 32 8 (1992) 691-699
29. Fox P.T., and Raichle M.E. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 83 4 (1986) 1140-1144
30. Parri R., and Crunelli V. An astrocyte bridge from synapse to blood flow. Nat Neurosci 6 1 (2003) 5-6
31. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 1 (2005) 67-81
32. Ming X., Stein T.P., Brimacombe M., Johnson W.G., Lambert G.H., and Wagner G.C. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 73 5 (2005) 379-384
33. Pratico D., Lawson J.A., Rokach J., and FitzGerald G.A. The isoprostanes in biology and medicine. Trends Endocrinol Metab 12 6 (2001) 243-247
34. Yao Y., Walsh W.J., McGinnis W.R., and Pratico D. Altered vascular phenotype in autism: correlation with oxidative stress. Arch Neurol 63 8 (2006) 1161-1164
35. Lu DY, Liou HC, Tang CH, Fu WM. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1α. Biochem Pharmacol 2006. doi:10.1016/j.bcp.2006.06.038, in press.
36. Ichiyama T., Nishikawa M., Hayashi T., Koga M., Tashiro N., and Furukawa S. Cerebral hypoperfusion during acute Kawasaki Disease. Stroke 29 7 (1998) 1320-1321
37. Huang W.S., Chiu P.Y., Tsai C.H., Kao A., and Lee C.C. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol Int 22 5 (2002) 178-181
38. Postiglione A., De Chiara S., Soricelli A., et al. Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus. Int J Clin Lab Res 28 1 (1998) 34-38
39. Lass P., Krajka-Lauer J., Homziuk M., et al. Cerebral blood flow in Sjögren's syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun 21 1 (2000) 31-35
40. Caca I., Nazaroglu H., Unlu K., Cakmak S.S., Ari S., and Sakalar Y.B. Color Doppler imaging of ocular hemodynamic changes in Behçet's disease. Jpn J Ophthalmol 48 2 (2004) 101-105
41. Wakamoto H., Ohta M., Nakano N., and Kunisue K. SPECT in focal enterovirus encephalitis: evidence for local cerebral vasculitis. Pediatr Neurol 23 5 (2000) 429-431
42. Nishikawa M., Matsubara T., Yoshitomi T., Ichiyama T., Hayashi T., and Furukawa S. Abnormalities of brain perfusion in echovirus type 30 meningitis. J Neurol Sci 179 S1-2 (2000) 122-126
43. Mathieu A., Sanna G., Mameli A., et al. Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus. Lupus 11 1 (2002) 52-56
44. Liu F.Y., Huang W.S., Kao C.H., Yen R.F., Wang J.J., and Ho S.T. Usefulness of Tc-99m ECD brain SPECT to evaluate the effects of methylprednisolone pulse therapy in lupus erythematosus with brain involvement: a preliminary report. Rheumatol Int 23 4 (2003) 182-185
45. Nathan C. Immunology: oxygen and the inflammatory cell. Nature 422 6933 (2003) 675-676
46. Cramer T., Yamanishi Y., Clausen B.E., et al. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation. Cell 112 5 (2003) 645-657
47. Cramer T., and Johnson R.S. A novel role for the hypoxia inducible transcription factor HIF-1α: critical regulation of inflammatory cell function. Cell Cycle 2 3 (2003) 192-193
48. Ryan H.E., Lo J., and Johnson R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 17 11 (1998) 3005-3015
49. Lu G., Qian X., Berezin I., Telford G.L., Huizinga J.D., and Sarna S.K. Inflammation modulates in vitro colonic myoelectric and contractile activity and interstitial cells of Cajal. Am J Physiol 273 6 Pt 1 (1997) G1233-G1245
50. Ishii Y., Ushida T., Tateishi T., Shimojo H., and Miyanaga Y. Effects of different exposures of hyperbaric oxygen on ligament healing in rats. J Orthop Res 20 2 (2002) 353-356
51. Harrison D.K., Abbot N.C., Carnochan F.M., Beck J.S., James P.B., and McCollum P.T. Protective regulation of oxygen uptake as a result of reduced oxygen extraction during chronic inflammation. Adv Exp Med Biol 345 (1994) 789-796
52. Van de Veire N.R., De Winter O., Philippe J., et al. Maximum oxygen uptake at peak exercise in elderly patients with coronary artery disease and preserved left ventricular function: the role of inflammation on top of tissue Doppler-derived systolic and diastolic function. Am Heart J 152 2 (2006) 297e.1-297e.7
53. Suematsu M., Schmid-Schonbein G.W., Chavez-Chavez R.H., et al. In vivo visualization of oxidative changes in microvessels during neutrophil activation. Am J Physiol 264 3Pt2 (1993) H881-H891
54. Miljkovic-Lolic M., Silbergleit R., Fiskum G., and Rosenthal R.E. Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity. Brain Res 971 1 (2003) 90-94
55. Sheffield P.J., and Davis J.C. Application of hyperbaric oxygen therapy in a case of prolonged cerebral hypoxia following rapid decompression. Aviat Space Environ Med 47 7 (1976) 759-762
56. Neubauer R.A., and James P. Cerebral oxygenation and the recoverable brain. Neurol Res 20 Suppl. 1 (1998) S33-S36
57. Al-Waili N.S., and Butler G.J. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. Scientific World J 6 (2006) 425-441
58. Banasiak K.J., Xia Y., and Haddad G.G. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 62 3 (2000) 215-249
59. Carmeliet P., Dor Y., Herbert J.M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 6692 (1998) 485-490
60. Ostrowski R.P., Colohan A.R., and Zhang J.H. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 25 5 (2005) 554-571
61. Lou M., Chen Y., Ding M., Eschenfelder C.C., and Deuschl G. Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia. Brain Res Bull 69 2 (2006) 109-116
62. Wada K., Miyazawa T., Nomura N., et al. Mn-SOD and Bcl-2 expression after repeated hyperbaric oxygenation. Acta Neurochir Suppl 76 (2000) 285-290
63. Fatemi S.H., Stary J.M., Halt A.R., and Realmuto G.R. Dysregulation of reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 31 6 (2001) 529-535
64. Atochin D.N., Fisher D., Demchenko I.T., and Thom S.R. Neutrophil sequestration and the effect of hyperbaric oxygen in a rat model of temporary middle cerebral artery occlusion. Undersea Hyperb Med 27 4 (2000) 185-190
65. Vlodavsky E., Palzur E., and Soustiel J.F. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix meralloproteinase-9 in the rat model of traumatic brain injury. Neuropathol Appl Neurobiol 32 1 (2006) 40-50
66. Thom S.R. Effects of hyperoxia on neutrophil adhesion. Undersea Hyperb Med 31 1 (2004) 123-131
67. Zamboni W.A., Roth A.C., Russell R.C., Graham B., Suchy H., and Kucan J.O. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 91 6 (1993) 1110-1123
68. Williams R.L. Hyperbaric oxygen therapy and the diabetic foot. J Am Podiatr Med Assoc 87 6 (1997) 279-292
69. Efrati S, Bergan J, Fishlev G, Tishler M, Golik A, Gall N. Hyperbaric oxygen therapy for nonhealing vasculitic ulcers. Clin Dermatol, in press. doi:10.1111/j.1365-2230.2006.02240.x.
70. Stoller K.P. Quantification of neurocognitive changes before, during, and after hyperbaric oxygen therapy in a case of fetal alcohol syndrome. Pediatrics 116 4 (2005) e586-e591
71. Montgomery D., Goldberg J., Amar M., et al. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. Undersea Hyperb Med 26 4 (1999) 235-242
72. Collet J.P., Vanasse M., Marois P., et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. Lancet 357 9256 (2001) 582-586
73. Heuser G., Heuser S.A., Rodelander D., Aguilera O., and Uszler M. Treatment of neurologically impaired adults and children with "mild" hyperbaric oxygenation (1.3 ATM and 24% oxygen). In: Joiner J.T. (Ed). Hyperbaric oxygenation for cerebral palsy and the brain-injured child (2002), Best Publications, Flagstaff Arizona 109-115
74. Golden Z.L., Neubauer R., Golden C.J., Greene L., Marsh J., and Mleko A. Improvement in cerebral metabolism in chronic brain injury after hyperbaric oxygen therapy. Int J Neurosci 112 2 (2002) 119-131
75. Rockswold G.L., Ford S.E., Anderson D.C., Bergman T.A., and Sherman R.E. Results of a prospective randomized trial for the treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg 76 6 (1992) 929-934
76. Nighoghossian N., Trouillas P., Adeleine P., and Salord F. Hyperbaric oxygen in the treatment of acute ischemic stroke. Stroke 26 (1995) 1369-1372
77. Ersoz G., Ocakcioglu B., Bastug M., Ficicilar H., and Yavuzer S. Platelet aggregation and release function in hyperbaric oxygenation. Undersea Hyperb Med 25 4 (1998) 229-232
78. Pardo C.A., Vargas D.L., and Zimmerman A.W. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 17 6 (2005) 485-495
79. Laurence J.A., and Fatemi S.H. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4 3 (2005) 206-210
80. Weizman A., Wiezman R., Szekely G.A., Wijsenbeek H., and Livni E. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am J Psychiatry 139 11 (1982) 1462-1465
81. Ahlsen G., Rosengren L., Belfrage M., et al. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol Psychiatry 33 10 (1993) 734-743
82. Singh V.K., Warren R., Averett R., and Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17 1 (1997) 88-90
83. Singer H.S., Morris C.M., Williams P.N., Yoon D.Y., Hong J.J., and Zimmerman A.W. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 178 1-2 (2006) 149-155
84. Connolly A.M., Chez M.G., Pestronk A., Arnold S.T., Mehta S., and Deuel R.K. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr 134 5 (1999) 607-613
85. Vojdani A., Campbell A.W., Anyanwu E., Kashanian A., Bock K., and Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol 129 1-2 (2002) 168-177
86. Vojdani A., O'Bryan T., Green J.A., et al. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci 7 3 (2004) 151-161
87. Singh V.K., Lin S.X., Newell E., and Nelson C. Abnormal measles-mump-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 9 4 (2002) 359-364
88. Singh V.K., Warren R.P., Odell J.D., Warren W.L., and Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 7 1 (1993) 97-103
89. Singh V.K., and Rivas W.H. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett 355 1-2 (2004) 53-56
90. Connolly A.M., Chez M., Streif E.M., et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59 4 (2006) 354-363
91. Dalton P., Deacon R., Blamire A., et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol 53 4 (2003) 533-537
92. Wakefield A.J., Ashwood P., Limb K., and Anthony A. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 17 8 (2005) 827-836
93. Uhlmann V., Martin C.M., Sheils O., et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. J Clin Pathol: Mol Pathol 55 2 (2002) 84-90
94. Furlano R.I., Anthony A., Day R., et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 138 3 (2001) 366-372
95. Balzola F., Barbon V., Repici A., et al. Panenteric IBD-like disease in a patient with regressive autism shown for the first time by the wireless capsule enteroscopy: another piece in the jigsaw of this gut-brain syndrome?. Am J Gastroenterol 100 4 (2005) 979-981
96. Torrente F., Ashwood P., Day R., et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7 4 (2002) 375-382
97. Ashwood P., Anthony A., Torrente F., and Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24 6 (2004) 664-673
98. Ashwood P., Anthony A., Pellicer A.A., Torrente F., Walker-Smith J.A., and Wakefield A.J. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 23 6 (2003) 504-517
99. Vojdani A., Pangborn J.B., Vojdani E., and Cooper E.L. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol 16 3 (2003) 189-199
100. Jyonouchi H., Sun S., and Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120 1-2 (2001) 170-179
101. Becker KG, Freidlin B, Simon RM. Comparative genomics of autism, Tourette syndrome and autoimmune/inflammatory disorders. http://www.grc.nia.nih.gov/branches/rrb/dna/pubs/cgoatad.pdf. April 23, 2003 [accessed 9.26.06].
102. Wakefield A.J., Puleston J.M., Montgomery S.M., Anthony A., O'Leary J.J., and Murch S.H. Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther 16 4 (2002) 663-674
103. Shenoy S., Arnold S., and Chatila T. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. J Pediatr 136 5 (2000) 682-687
104. Stefanatos G.A., Grover W., and Geller E. Case study: corticosteroid treatment of language regression in pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry 34 8 (1995) 1107-1111
105. Akin M.L., Gulluoglu B.M., Uluutku H., et al. Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med 29 4 (2002) 279-285
106. Luongo C., Imperatore F., Cuzzocrea S., et al. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 26 12 (1998) 1972-1976
107. Sumen G., Cimsit M., and Eroglu L. Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in rats. Eur J Pharmacol 431 2 (2001) 265-268
108. Weisz G., Lavy A., Adir Y., et al. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 17 2 (1997) 154-159
109. Yang Z.J., Bosco G., Montante A., Ou X.I., and Camporesi E.M. Hyperbaric oxygen reduces intestinal ischemia-reperfusion-induced TNF-alpha production and lung neutrophil sequestration. Eur J Appl Physiol 85 1-2 (2001) 96-103
110. Benson R.M., Minter L.M., Osborne B.A., and Granowitz E.V. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol 134 1 (2003) 57-62
111. Yang Z., Nandi J., Wang J., et al. Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by Modulating TNF-alpha and IL-1beta production. Dig Dis Sci 51 8 (2006) 1426-1433
112. Inamoto Y., Okuno F., Saito K., et al. Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Commun 179 2 (1991) 886-891
113. Buras J.A., Holt D., Orlow D., Belikoff B., Pavlides S., and Reenstra W.R. Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 34 10 (2006) 2624-2629
114. Wilson H.D., Wilson J.R., and Fuchs P.N. Hyperbaric oxygen treatment decreases inflammation and mechanical hypersensitivity in an animal model of inflammatory pain. Brain Res 1098 1 (2006) 126-128
115. Warren J., Sacksteder M.R., and Thuning C.A. Therapeutic effect of prolonged hyperbaric oxygen in adjuvant arthritis of the rat. Arthritis Rheum 22 4 (1979) 334-339
116. Tokar B., Gundogan A.H., Ilhan H., Bildirici K., Gultepe M., and Elbuken E. The effects of hyperbaric oxygen treatment on the inflammatory changes caused by intraperitoneal meconium. Pediatr Surg Int 19 9-10 (2003) 673-676
117. Rachmilewitz D., Karmeli F., Okon E., Rubenstein I., and Better O.S. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 43 4 (1998) 512-518
118. Gulec B., Yasar M., Yildiz S., et al. Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res 53 5 (2004) 493-499
119. Gorgulu S., Yagci G., Kaymakcioglu N., et al. Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats. Dig Dis Sci 51 3 (2006) 480-487
120. Takeshima F., Makiyama K., and Doi T. Hyperbaric oxygen as adjunct therapy for Crohn's intractable enteric ulcer. Am J Gastroenterol 94 11 (1999) 3374-3375
121. Colombel J.F., Mathieu D., Bouault J.M., et al. Hyperbaric oxygenation in severe perineal Crohn's disease. Dis Colon Rectum 38 6 (1995) 609-614
122. Nelson Jr. E.W., Bright D.E., and Villar L.F. Closure of refractory perineal Crohn's lesion: integration of hyperbaric oxygen into case management. Dig Dis Sci 35 12 (1990) 1561-1565
123. Lavy A., Weisz G., Adir Y., Ramon Y., Melamed Y., and Eidelman S. Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 19 3 (1994) 202-205
124. Brady III C.E., Cooley B.J., and Davis J.C. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen. Gastroenterology 97 3 (1989) 756-760
125. Buchman A.L., Fife C., Torres C., Smith L., and Aristizibal J. Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 33 4 (2001) 337-339
126. Gurbuz A.K., Elbuken E., Yazgan Y., and Yildiz S. A different therapeutic approach in patients with severe ulcerative colitis: hyperbaric oxygen treatment. South Med J 96 6 (2003) 632-633
127. Shiratsuch H., and Basson M.D. Differential regulation of monocyte/macrophage cytokine production by pressure. Am J Surg 190 5 (2005) 757-762
128. Granowitz E.V., Skulsky E.J., Benson R.M., et al. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-γ secretion in whole blood cultures of healthy humans. Undersea Hyperb Med 29 3 (2002) 216-225
129. Yin W., Badr A.E., Mychaskiw G., and Zhang J.H. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal ischemia model. Brain Res 926 1-2 (2002) 165-171
130. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., and Gregory S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97 11 (1996) 2672-2679
131. Ashwood P., and Van de Water J. A review of autism and the immune response. Clin Dev Immunol 11 2 (2004) 165-174
132. Sweeten T.L., Bowyer S.L., Posey D.J., Halberstadt G.M., and McDougle C.J. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112 5 (2003) e420
133. Valicenti-McDermott M., McVicar K., Rapin I., Wershil B.K., Cohen H., and Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 27 Suppl. 2 (2006) S128-S136
134. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., and Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14 6 (1999) 388-394
135. Croonenberghs J., Wauters A., Devreese K., et al. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 32 8 (2002) 1457-1463
136. Stubbs E.G. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr 6 3 (1976) 269-274
137. Evers M., Cunningham-Rundles C., and Hollander E. Heat shock protein 90 antibodies in autism. Mol Psychiatry 7 Suppl. 2 (2002) S26-S28
138. Queitsch C., Sangster T.A., and Lindquist S. Hsp90 as a capacitor of phenotypic variation. Nature 417 6889 (2002) 618-624
139. Gupta S., Aggarwal S., and Heads C. Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 26 4 (1996) 439-452
140. Gupta S. Immunological treatments for autism. J Autism Dev Disorder 30 5 (2000) 475-479
141. Plioplys A.V. Intravenous immunoglobulin treatment of children with autism. J Child Neurol 13 2 (1998) 79-82
142. Denney D.R., Frei B.W., and Gaffney G.R. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord 26 1 (1996) 87-97
143. Warren R.P., Margaretten N.C., Pace N.C., and Foster A. Immune abnormalities in patients with autism. J Autism Dev Disord 16 2 (1986) 189-197
144. Scifo R., Cioni M., and Nicolosi A. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Ann Ist Super Sanita 32 3 (1996) 351-359
145. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
146. Ngoc P.L., Gold D.R., Tzianabos A.O., Weiss S.T., and Celedon J.C. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 5 2 (2005) 161-166
147. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., and Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 159 2 (2005) 151-157
148. Lucarelli S., Frediani T., Zingoni A.M., et al. Food allergy and infantile autism. Panminerva Med 37 3 (1995) 137-141
149. Singh V.K. Plasma increase of interleukin-12 and interferon-gamma: Pathological significance in autism. J Neuroimmunol 66 1-2 (1996) 143-145
150. Stubbs G. Interferonemia and autism. J Autism Dev Disord 25 1 (1995) 71-73
151. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., and Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 45 1 (2002) 1-6
152. Messahel S., Pheasant A.E., Pall H., Ahmed-Choudhury J., Sungum-Paliwal R.S., and Vostanis P. Urinary levels of neopterin and biopterin in autism. Neurosci Lett 241 1 (1998) 17-20
153. Gupta S., Aggarwal S., Rashanravan B., and Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 85 1 (1998) 106-109
154. Molloy C.A., Morrow A.L., Meinzen-Derr J., et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172 1-2 (2006) 198-205
155. Stubbs E.G., and Crawford M.L. Depressed lymphocytes responsiveness in autistic children. J Autism Child Schizophr 7 1 (1977) 49-55
156. Warren R.P., Foster A., and Margaretten N.C. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psych 26 3 (1987) 333-335
157. Xu X., Yi H., Kato M., et al. Differential sensitivities to hyperbaric oxygen of lymphocyte subpopulations of normal and autoimmune mice. Immunol Lett 59 2 (1997) 79-84
158. Wallace D.J., Silverman S., Goldstein J., and Hughes D. Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus 4 3 (1995) 172-175
159. Lukich V.L., Poliakova L.V., Sotnikova T.I., and Belokrinitskii D.V. Hyperbaric oxygenation in the comprehensive therapy of patients with rheumatoid arthritis. FIZIOL ZH 37 5 (1991) 55-60
160. Warren J., Sacksteder M.R., and Thuning C.A. Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. J Immunol 121 1 (1978) 315-320
161. Erdmann D., Roth A.C., Hussmann J., et al. Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice. Undersea Hyperb Med 22 4 (1995) 395-399
162. Saito K., Tanaka Y., Ota T., Eto S., and Yamashita U. Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice. Clin Exp Immunol 86 2 (1991) 322-327
163. Chen S.Y., Chen Y.C., Wang J.K., et al. Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB X NZW) F1 mice. Clin Immunol 108 2 (2003) 103-110
164. Olszanski R., Pachut M., Sicko Z., Sztaba-Kania M., and Wilkowska A. Efficacy of hyperbaric oxygenation in atopic dermatitis. Bull Inst Marit Trop Med Gdynia 43 1-4 (1992) 79-82
165. Nyland H., Naess A., Eidsvik S., Glette J., Matre R., and Hordnes C. Effect of hyperbaric oxygen treatment on immunological parameters in multiple sclerosis. Acta Neurol Scand 79 4 (1989) 306-310
166. Lee A.K., Hester R.B., Coggin J.H., and Gottlieb S.F. Increased oxygen tensions modulate the cellular composition of the adaptive immune system in BALB/c mice. Cancer Biother 8 3 (1993) 241-252
167. Lee A.K., Hester R.B., Coggin J.H., and Gottlieb S.F. Increased oxygen tensions influence subset composition of the cellular immune system in aged mice. Cancer Biother 9 1 (1994) 39-54
168. Thom S.R., Bhopale V., Fisher D., Manevich Y., Huang P.L., and Buerk D.G. Stimulation of nitric oxide synthase in cerebral cortex due to elevated partial pressures of oxygen: an oxidative stress response. J Neurobiol 51 2 (2002) 85-100
169. van den Blink B., van der Kleij A.J., Versteeg H.H., and Peppelenbosch M.P. Immunomodulatory effect of oxygen and pressure. Comp Biochem Physiol A Mol Integr Physiol 132 1 (2002) 193-197
170. James S.J., Cutler P., Melnyk S., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80 6 (2004) 1611-1617
171. James SJ, Melnyk S, Jernigan S, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet Part B, in press. doi:10.1002/ajmg.b.30366.
172. Sogut S., Zoroglu S.S., Ozyurt H., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331 1-2 (2003) 111-117
173. McGinnis W.R. Oxidative stress in autism. Altern Ther Health Med 10 6 (2004) 22-36
174. Zoroglu S.S., Armutcu F., Ozen S., et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254 3 (2004) 143-147
175. Chauhan A., Chauhan V., Brown W.T., and Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sci 75 21 (2004) 2539-2549
176. Yorbik O., Sayal A., Akay C., Akbiyik D.I., and Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 67 5 (2002) 341-343
177. D'Amelio M., Ricci I., Sacco R., et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry 10 11 (2005) 1006-1016
178. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., and Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57 9 (2001) 1618-1628
179. Yorbik O., Akay C., Sayal A., Cansever A., Sohmen T., and Cavdar A.O. Zinc status in autistic children. J Trace Elem Exp Med 17 2 (2004) 101-107
180. Adams J.B., and Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med 10 6 (2004) 1033-1039
181. Dolske M.C., Spollen J., McKay S., Lancashire E., and Tolbert L. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry 17 5 (1993) 765-774
182. Alleva R., Nasole E., Di Donato F., Borghi B., Neuzil J., and Tomasetti M. alpha-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy. Biochem Biophys Res Commun 333 2 (2005) 404-410
183. Wada K., Miyazawa T., Nomura N., Tsuzuki N., Nawashiro H., and Shima K. Preferential conditions for and possible mechanisms of induction of ischemic tolerance by repeated hyperbaric oxygenation in gerbil hippocampus. Neurosurgery 49 1 (2001) 160-167
184. Yatsuzuka H. Effects of hyperbaric oxygen therapy on ischemic brain injury in dogs. Masui 40 2 (1991) 208-223
185. Ozden T.A., Uzun H., Bohloli M., et al. The effects of hyperbaric oxygen treatment on oxidative and antioxidants levels during liver regeneration in rats. Tohoku J Exp Med 203 4 (2004) 253-265
186. Yasar M., Yildiz S., Mas R., et al. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res 52 1 (2003) 111-116
187. Kudchodkar B.J., Wilson J., Lacko A., and Dory L. Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 20 6 (2000) 1637-1643
188. Gregorevic P., Lynch G.S., and Williams D.A. Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles. Eur J Appl Physiol 86 1 (2001) 24-27
189. Nie H., Xiong L., Lao N., Chen S., Xu N., and Zhu Z. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab 26 5 (2006) 666-674
190. Sharifi M., Fares W., Abdel-Karim I., et al. Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. Am J Cardiol 93 12 (2004) 1533-1535
191. Speit G., Dennog C., Eichhorn U., Rothfuss A., and Kaina B. Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment. Carcinogenesis 21 10 (2000) 1795-1799
192. Rothfuss A., Radermacher P., and Speit G. Involvement of heme-oxygenase-1 (HO-1) in the adaptive protection of human lymphocytes after hyperbaric oxygen (HBO) treatment. Carcinogenesis 22 12 (2001) 1979-1985
193. Rothfuss A., and Speit G. Investigations on the mechanism of hyperbaric oxygen (HBO)-induced adaptive protection against oxidative stress. Mutat Res 508 1-2 (2002) 157-165
194. Dennog C., Radermacher P., Barnett Y.A., and Speit G. Antioxidant status in humans after exposure to hyperbaric oxygen. Mutat Res 428 1-2 (1999) 83-89
195. Shyu W.C., Lin S.Z., Saeki K., et al. Hyperbaric oxygen enhances the expression of prion protein and heat shock protein 70 in a mouse neuroblastoma cell line. Cell Mol Neurobiol 24 2 (2004) 257-268
196. Ostrowski R.P., Tang J., and Zhang J.H. Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke 37 5 (2006) 1314-1318
197. Moak S.A., and Greenwald R.A. Enhancement of rat serum ceruloplasmin levels by exposure to hyperoxia. Proc Soc Exp Biol Med 177 1 (1984) 97-103
198. Pasca S.P., Nemes B., Vlase L., et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 78 19 (2006) 2244-2248
199. Lombard J. Autism: a mitochondrial disorder?. Med Hypotheses 50 6 (1998) 497-500
200. Filipek P.A., Juranek J., Smith M., et al. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol 53 6 (2003) 801-804
201. Poling J.S., Frye R.E., Shoffner J., and Zimmerman A.W. Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol 21 2 (2006) 170-172
202. Clark-Taylor T., and Clark-Taylor B.E. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial β-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses 62 6 (2004) 970-975
203. Fillano J.J., Goldenthal M.J., Rhodes C.H., and Marin-Garcia J. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol 17 6 (2002) 435-439
204. Filipek P.A., Juranek J., Nguyen M.T., Cummings C., and Gargus J.J. Relative carnitine deficiency in autism. J Autism Dev Disord 34 6 (2004) 615-623
205. Graf W.D., Marin-Garcia J., Gao H.G., et al. Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol 15 6 (2000) 357-361
206. Ramoz N., Reichert J.G., Smith C.J., et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 161 4 (2004) 662-669
207. Segurado R., Conroy J., Meally E., Fitzgerald M., Gill M., and Gallagher L. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am J Psychiatry 162 11 (2005) 2182-2184
208. Pons R., Andreu A.L., Checcarelli N., et al. Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 144 1 (2004) 81-85
209. Lerman-Sagie T., Leshinsky-Silver E., Watemberg N., and Lev D. Should autistic children be evaluated for mitochondrial disorders?. J Child Neurol 19 5 (2004) 379-381
210. Oliveira G., Diogo L., Grazina M., et al. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47 3 (2005) 185-199
211. Kriaucionis S., Paterson A., Curtis J., Guy J., MacLeod N., and Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett Syndrome. Mol Cell Biol 26 13 (2006) 5033-5042
212. Magalhães J., Ascensão A., Soares J.M.C., et al. Acute and severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse skeletal muscle. J Appl Physiol 99 (2005) 1247-1253
213. Lane N. Oxygen: the molecule that made the world (2002), Oxford University Press p. 166-7
214. Daugherty W.P., Levasseur J.E., Sun D., Rockswold G.L., and Bullock M.R. Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats. J Neurosurg 101 3 (2004) 499-504
215. Dave K.R., Prado R., Busto R., et al. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience 120 1 (2003) 113-120
216. Boveris A., and Chance B. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem J 134 3 (1973) 707-716
217. Gosalvez M., Castillo Olivares J., De Miguel E., Blanco M., and Figuera D. Mitochondrial respiration and oxidative phosphorylation during hypothermic hyperbaric hepatic preservation. J Surg Res 15 5 (1973) 313-318
218. Bar-Sagie D., Mayevsky A., and Bartoov B. Effects of hyperbaric oxygenation on spermatozoan motility driven by mitochondrial respiration. J Appl Physiol 50 3 (1981) 531-537
219. Gutsaeva D.R., Suliman H.B., Carraway M.S., Demchenko I.T., and Piantadosi C.A. Oxygen-induced mitochondrial biogenesis in the rat hippocampus. Neuroscience 137 2 (2006) 493-504
220. Chugani D.C., Muzik O., Behen M., et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45 3 (1999) 287-295
221. Connors S.L., Matteson K.J., Sega G.A., Lozzio C.B., Carroll R.C., and Zimmerman A.W. Plasma serotonin in autism. Pediatr Neurol 35 (2006) 182-186
222. Croonenberghs J., Delmeire L., Verkerk R., et al. Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology 22 3 (2000) 275-283
223. McDougle C.J., Naylor S.T., Cohen D.J., Aghajanian G.K., Heninger G.R., and Price L.H. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53 11 (1996) 993-1000
224. Todd R.D., and Ciaranello R.D. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci, USA 82 2 (1985) 612-616
225. Singh V.K., Singh E.A., and Warren R.P. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol Psychiatry 41 6 (1997) 753-755
226. McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., and Price L.H. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53 11 (1996) 1001-1008
227. Hollander E., Phillips A., Chaplin W., et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30 3 (2005) 582-589
228. Owley T., Walton L., Salt J., et al. An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 44 4 (2005) 343-348
229. Gillberg C., and Svennerholm L. CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 151 (1987) 89-94
230. Young J.G., Kavanagh M.E., Anderson G.M., Shaywitz B.A., and Cohen D.J. Clinical neurochemistry of autism and associated disorders. J Autism Dev Disord 12 2 (1982) 147-165
231. Ernst M., Magee H.J., Gonzalez N.M., Locascio J.J., Rosenberg C.R., and Campbell M. Pimozide in autistic children. Psychopharmacol Bull 28 2 (1992) 187-191
232. Simon-Soret C., and Borenstein P. A trial of bromocriptine in the treatment of infantile autism. Presse Med 16 26 (1987) 1286 [in French]
233. Fisher A.B., Block E.R., and Pietra G. Environmental influences on uptake of serotonin and other amines. Environ Health Perspect 35 (1980) 191-198
234. Block E.R., and Stalcup S.A. Depression of serotonin uptake by cultured endothelial cells exposed to high O2 tension. J Appl Physiol 50 6 (1981) 1212-1219
235. Sumen-Secgin G., Cimsit M., Ozek M., and Eroglu L. Antidepressant-like effect of hyperbaric oxygen treatment in forced-swimming test in rats. Methods Find Exp Clin Pharmacol 27 7 (2005) 471-474
236. Di Sabato F., Rocco M., Martelletti M., and Giacovazzo M. Hyperbaric oxygen in chronic cluster headaches: influence on serotonergic pathways. Undersea Hyperb Med 24 2 (1997) 117-122
237. Yang Z., Camporesi C., Yang X., et al. Hyperbaric oxygenation mitigates focal cerebral injury and reduces striatal dopamine release in a rat model of transient middle cerebral artery occlusion. Eur J Appl Physiol 87 2 (2002) 101-107
238. Adachi Y.U., Watanabe K., Higuchi H., Satoh T., and Vizi E.S. Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study. Eur J Pharmacol 422 1-3 (2001) 61-68
239. Worth J. Paraoxonase polymorphisms and organophosphates. Lancet 360 9335 (2002) 802-803
240. Finegold S.M., Molitoris D., Song Y., et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35 Suppl. 1 (2002) S6-S16
241. Song Y., Liu C., and Finegold S.M. Real-time PCR quantitation of Clostridia in feces of autistic children. Appl Environ Microbiol 70 11 (2004) 6459-6465
242. Parracho H.M., Bingham M.O., Gibson G.R., and McCartney A.L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54 Pt 10 (2005) 987-991
243. Bolte E.R. Autism and Clostridium tetani. Med Hypotheses 51 2 (1998) 133-144
244. Sandler R.H., Finegold S.M., Bolte E.R., et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15 7 (2000) 429-435
245. Cave S. Autism in children. Int J Pharmaceut Compd 5 1 (2001) 18-19
246. Knighton D.R., Halliday B., and Hunt T.K. Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg 119 2 (1984) 199-204
247. Akin M.L., Erenoglu C., Dal A., Erdemoglu A., Elbuken E., and Batkin A. Hyperbaric oxygen prevents bacterial translocation in rats with obstructive jaundice. Dig Dis Sci 46 8 (2001) 1657-1662
248. Gottlieb S.F. Effect of hyperbaric oxygen on microorganisms. Annu Rev Microbiol 25 (1971) 111-152
249. Bornside G.H., Pakman L.M., and Ordonez Jr. A.A. Inhibition of pathogenic enteric bacteria by hyperbaric oxygen: enhanced antibacterial activity in the absence of carbon dioxide. Antimicrob Agents Chemother 7 5 (1975) 682-687
250. Clark J.M., and Pakman L.M. Inhibition of pseudomonas aeruginosa by hyperbaric oxygen: II. Ultrastructural changes. Infect Immun 4 4 (1971) 488-491
251. Bornside G.H. Enhancement of antibiotic activity against staphylococcus aureus by exposure to hyperbaric oxygen. Appl Microbiol 15 5 (1967) 1020-1024
252. Unsworth I.P., and Sharp P.A. Gas Gangrene. An 11-year review of 73 cases managed with hyperbaric oxygen. Med J Aust 140 5 (1984) 256-260
253. Babior B.M. Oxygen-dependent microbial killing by phagocytes: Part I. N Engl J Med 298 12 (1978) 659-668
254. Mader J.T., Brown G.L., Guckian J.C., Wells C.H., and Reinarz J.A. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 142 6 (1980) 915-922
255. Arao T., Hara Y., Suzuki Y., and Tamura K. Effects of high-pressure gas on yeast growth. Biosci Biotechnol Biochem 69 7 (2005) 1365-1371
256. Baugh M.A. HIV: reactive oxygen species, enveloped viruses and hyperbaric oxygen. Med Hypotheses 55 3 (2000) 232-238
257. Reillo M.R., and Altieri R.J. HIV antiviral effects of hyperbaric oxygen therapy. J Assoc Nurses AIDS Care 7 1 (1996) 43-45
258. Libet B., and Siegel B.V. Response of a virus-induced leukemia in mice to high oxygen tension. Cancer Res 22 6 (1962) 737-742
259. Arrais-Silva W.W., Collhone M.C., Ayres D.C., de Souza Souto P.C., and Giorgio S. Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes. Parasitol Int 54 1 (2005) 1-7
260. Nataf R., Skorupka C., Amet L., Lam A., Springbett A., and Lathe R. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol 214 2 (2006) 99-108
261. Haley B.E., and Small T. Interview with Dr. Boyd E. Haley: biomarkers supporting mercury toxicity as the major exacerbator of neurological illness, recent evidence via the urinary porphyrin tests. Medical Veritas 3 (2006) 921-934
262. Thom S.R., Bhopale V.M., Velazquez O.C., Goldstein L.J., Thom L.H., and Buerk D.G. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol 290 4 (2006) H1378-H1386
263. Steindler D.A., and Pincus D.W. Stem cells and neuropoiesis in the adult human brain. Lancet 359 9311 (2002) 1047-1054
264. Mezey E., Key S., Vogelsang G., Szalayova I., Lange G.D., and Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci USA 100 3 (2003) 1364-1369
265. Cogle C.R., Yachnis A.T., Laywell E.D., et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 363 9419 (2004) 1432-1437
266. Marois P., and Vanasse M. Hyperbaric oxygen therapy and cerebral palsy. Dev Med Child Neurol 45 9 (2003) 646-648
267. Ashamalla H.L., Thom S.R., and Goldwein J.W. Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children: the University of Pennsylvania experience. Cancer 77 11 (1996) 2407-2412
268. Waalkes P., Fitzpatrick D.T., Stankus S., and Topolski R. Adjunctive HBO treatment of children with cerebral anoxic injury. Army Med Dept J April-June (2002) 13-21
269. In: Feldmeier J.J. (Ed). Hyperbaric oxygen 2003: indications and results: the hyperbaric oxygen therapy committee report (2003), Undersea and Hyperbaric Medical Society, Kensington, MD
270. Rossignol D.A., and Rossignol L.W. Hyperbaric oxygen therapy may improve symptoms in autistic children. Med Hypotheses 67 2 (2006) 216-228